Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$75.08
-1.17-1.53%
Last update: Dec 16, 12:29 PM
Comments
Loading...
PTC Therapeutics (PTCT) Stock Price, Quote, News & History
PTCTNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy PTC Therapeutics (PTCT) stock?
You can purchase shares of PTC Therapeutics (NASDAQ:PTCT) through any online brokerage.
Who are PTC Therapeutics (PTCT) competitors?
Other companies in PTC Therapeutics’s space includes: Immunovant Inc (NASDAQ:IMVT), Legend Biotech Corp (NASDAQ:LEGN), Cogent Biosciences Inc (NASDAQ:COGT), Celcuity Inc (NASDAQ:CELC) and Alkermes PLC (NASDAQ:ALKS).
What is the forecast, or price target, for PTC Therapeutics (PTCT) stock?
PTC Therapeutics has a consensus price target of $67.05.
What is the current price for PTC Therapeutics (PTCT)?
The stock price for PTC Therapeutics (NASDAQ: PTCT) is $75.08 last updated December 16, 2025 at 12:29 PM EST.
Does PTC Therapeutics (PTCT) pay a dividend?
There are no upcoming dividends for PTC Therapeutics.
When is PTC Therapeutics (NASDAQ:PTCT) reporting earnings?
PTC Therapeutics does not have any upcoming earnings scheduled.
Is PTC Therapeutics (PTCT) going to split?
There is no upcoming split for PTC Therapeutics.
What sector and industry does PTC Therapeutics (PTCT) operate in?
PTC Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
